These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11273215)

  • 1. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.
    Detels R; Tarwater P; Phair JP; Margolick J; Riddler SA; Muñoz A;
    AIDS; 2001 Feb; 15(3):347-55. PubMed ID: 11273215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
    Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States.
    Asch SM; Gifford AL; Bozzette SA; Turner B; Mathews WC; Kuromiya K; Cunningham W; Andersen R; Shapiro M; Rastegar A; McCutchan JA
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):340-4. PubMed ID: 11707670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
    Dankner WM; Lindsey JC; Levin MJ;
    Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.
    Gebo KA; Fleishman JA; Reilly ED; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III23-30. PubMed ID: 16116306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.
    Detels R; Muñoz A; McFarlane G; Kingsley LA; Margolick JB; Giorgi J; Schrager LK; Phair JP
    JAMA; 1998 Nov; 280(17):1497-503. PubMed ID: 9809730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.
    Charurat M; Blattner W; Hershow R; Buck A; Zorrilla CD; Watts DH; Paul M; Landesman S; Adeniyi-Jones S; Tuomala R;
    J Womens Health (Larchmt); 2004; 13(6):719-30. PubMed ID: 15333287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
    Palella FJ; Delaney KM; Moorman AC; Loveless MO; Fuhrer J; Satten GA; Aschman DJ; Holmberg SD
    N Engl J Med; 1998 Mar; 338(13):853-60. PubMed ID: 9516219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.
    Buchacz K; Lau B; Jing Y; Bosch R; Abraham AG; Gill MJ; Silverberg MJ; Goedert JJ; Sterling TR; Althoff KN; Martin JN; Burkholder G; Gandhi N; Samji H; Patel P; Rachlis A; Thorne JE; Napravnik S; Henry K; Mayor A; Gebo K; Gange SJ; Moore RD; Brooks JT;
    J Infect Dis; 2016 Sep; 214(6):862-72. PubMed ID: 27559122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic infections in HIV-AIdS.
    Paul SM
    N J Med; 2004 Nov; 101(11):25-31; quiz 32-4. PubMed ID: 15605797
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
    Schäfer G; Hoffmann C; Arasteh K; Schürmann D; Stephan C; Jensen B; Stoll M; Bogner JR; Faetkenheuer G; Rockstroh J; Klinker H; Härter G; Stöhr A; Degen O; Freiwald E; Hüfner A; Jordan S; Schulze Zur Wiesch J; Addo M; Lohse AW; van Lunzen J; Schmiedel S;
    AIDS Res Ther; 2019 Nov; 16(1):34. PubMed ID: 31729999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.
    Michaels SH; Clark R; Kissinger P
    Clin Infect Dis; 1999 Aug; 29(2):468-9. PubMed ID: 10476778
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of combined antiretroviral therapy on multiple AIDS-defining illnesses in an HIV seroconverter cohort].
    Ferreros I; Hurtado I; del Amo J; Muga R; del Romero J; García P; Alastrué I; Belda J; Guevara M; Pérez S;
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):179-84. PubMed ID: 21333403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis.
    Sungkanuparph S; Vibhagool A; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C
    AIDS; 2003 Sep; 17(14):2129-31. PubMed ID: 14502020
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
    Jacobson MA; French M
    AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection.
    Tellez I; Barragán M; Franco-Paredes C; Petraro P; Nelson K; Del Rio C
    Am J Med Sci; 2008 Mar; 335(3):192-7. PubMed ID: 18344692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.